DHL

Clinical trials for DHL explained in plain language.

Never miss a new study

Get alerted when new DHL trials appear

Sign up with your email to follow new studies for DHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for seniors with hard-to-treat lymphoma: drug combo targets double/triple-hit cancers

Disease control Not yet recruiting

This study tests a new combination of drugs for people aged 65 and older with a fast-growing type of lymphoma called double/triple-hit diffuse large B-cell lymphoma, who cannot have a stem cell transplant. The treatment includes several chemotherapy drugs plus two newer targeted …

Matched conditions: DHL

Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated May 07, 2026 17:51 UTC

DHL

Get alerted when new DHL trials appear

New hope for seniors with hard-to-treat lymphoma: drug combo targets double/triple-hit cancers